Navigation Links
Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Mar 19, 2007 - Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced positive results from its newly completed long-term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). 26 clinical trial sites across the U.S. and 116 unselected subjects participated in the blinded, placebo controlled study.

The study assessed symptom scores and treatment outcome 8-19 months after NX-1207 treatment. Overall, without further NX-1207 treatment, patients initially treated with NX-1207 showed a total pooled mean improvement of 7.4 points in the primary outcome endpoint of AUA Symptom Score values, which reached statistical significance when compared with the placebo control (p=.028).

In terms of treatment outcomes, patients treated with NX-1207 had statistically significantly more (p=.02) favorable outcomes compared to placebo.

There have been no significant sexual side effects from NX-1207.

Paul Averback MD, CEO of Nymox said, "Nymox is continuing to carefully move this drug ahead as rapidly as possible. This placebo-controlled blinded clinical study demonstrates a striking degree of long-term improvement in BPH patients given NX-1207, and confirms the promising results from the earlier completed U.S. clinical trials."

Dr. Averback added, "The durability of BPH symptom improvement from NX-1207 treatment is clearly shown by this new data, which is of special interest to potential marketing partners for NX-1207."

The Company previously completed three U.S. trials for NX-1207, including most recently a Phase 2 double-blind, placebo controlled, randomized multi-site U.S. study, which showed positive efficacy and safety results for NX-1207 after 3 months in patients with BPH. Overall, patients treated with NX-1207 showed after 3 months a mean improvement of 9.35 points in AUA Symptom Score values, the standard scale used to evaluate B
'"/>




Page: 1 2 3

Related medicine technology :

1. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
2. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
3. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
4. Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207 for BPH
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:8/22/2014)... , Aug. 22, 2014  Landauer, Inc. (NYSE: ... and environmental radiation measurement and monitoring, outsourced medical physics ... that William E. Saxelby , its President and ... and Chief Executive Officer and as a member of ... 2014.  He will be replaced on an interim basis ...
(Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
(Date:8/21/2014)... /CNW/ - Eisai Limited is pleased to support the Canadian ... book available in Canada . The comic ... educate children and their parents about epilepsy, the most common ... than 300,000 Canadians. Eisai is guided by a corporate philosophy ... the patient is central – there was a need within ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... YORK, Aug. 30, 2011 Reportlinker.com announces that ... in its catalogue: Pharmaceutical ... http://www.reportlinker.com/p0605649/Pharmaceutical-Distributors---Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory This register contains ... Europe. The register includes the following information ...
... 2011 Simon Orobor, owner of Power Wheelchair Services, ... added U-Haul truck and trailer rentals to the power ... been operating since 2009. (Logo: http://photos.prnewswire.com/prnh/20090622/LA34860LOGO-b ... photo accompanying this press release. Families ...
Cached Medicine Technology:Power Wheelchair Services, Inc. Assists Customers in More Ways Than One With U-Haul Products and Services 2Power Wheelchair Services, Inc. Assists Customers in More Ways Than One With U-Haul Products and Services 3
(Date:8/22/2014)... attained the distinguished Magnet hospital designation by the ... Considered the gold standard for nursing excellence, the ... professionalism. It is the top international credential for ... Newport Hospital was based on the hospital,s continued ... , "It is a privilege for us to ...
(Date:8/22/2014)... may do little to help young people with drinking ... studies that included nearly 18,000 people 25 and younger, ... problems. Participants in 49 studies attended a single one-on-one ... studies attended group sessions or a mix of group ... interviewing was used in the studies. This technique was ...
(Date:8/22/2014)... previous few years, several breakthrough treatments have become ... who may benefit from these treatments can be ... their cancer. For example, patients whose lung cancer ... derive significant benefit from the drug crizotinib, which ... now attempting to replicate this success by matching ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 ItsHot.com, a ... now offering 60-80% off on its range of beautiful ... the purchase of Gold Hearts 14K White Rose Gold ... a discount of 77%. Previously priced at $3,715.00, ... $859.00. The item code of this mesmerizing pendant embedded ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 “Dr. Luciana ... Luciana Lagana , aka Dr. Luciana, is finding it challenging ... budget and while taking care of hundreds of students, so ... trailer for the show is completed, and she recently entered ... fun projects including those of her husband, actor/screenwriter Gregory ...
Breaking Medicine News(10 mins):Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4Health News:ItsHot.com Now Offers 60-80% Discount on its Striking Collection of Diamond Heart Pendants 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4
... of new guidelines for cardiac specialists has been developed ... mechanical heart-pumping device. "The new guidelines will likely ... device, and how early in the process a physician ... Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- ... showing early signs of dementia, researchers from the University of ... diagnose which type of dementia a patient has and start ... dementia patients tended to have difficulty identifying the form of ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, ... chronic urinary tract infections, but now a new treatment ... a preliminary trial indicates. Urinary tract infections frequently ... all women. The depletion of vaginal Lactobacillus crispatus ...
... , FRIDAY, April 15 (HealthDay News) -- Teens who start ... traffic crashes, a new study finds. But starting the ... and reduce impulsiveness, another study finds. In 2008, the ... Beach, Va., was about 41 percent higher than for the ...
... Steven Reinberg HealthDay Reporter , THURSDAY, April 14 ... increase in hard times and decrease during years of prosperity, ... of people jumping from windows after the stock market crash ... the U.S. Centers for Disease Control and Prevention. "The ...
... A study in the April 15 issue of the Journal ... teen drivers who start school earlier in the morning. Results ... 18-year-olds was about 41 percent higher in Virginia Beach, Va., where ... adjacent Chesapeake, Va., where classes started at 8:40 - 8:45 a.m. ...
Cached Medicine News:Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:New Treatment for Urinary Tract Infections Called Promising 2Health News:New Treatment for Urinary Tract Infections Called Promising 3Health News:Early School Start Tied to More Teen Crashes: Study 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 3Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 2Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 3
Titanium forceps with gently curved jaws and ultra fine sharpened tips for puncture and grasping the capsule. Round handle is excellent for precise finger-tip control...
Straight shafts with 4 mm jaws. Serrated handle with dull finish. Jaws angled 45 degrees....
Straight shafts with fine tips and dull finish. Insulated stop with tip gap set at 0.3 mm. Smooth handle....
Straight shafts with rounded tips. Smooth handle with dull finish....
Medicine Products: